Filter by
Sort by
Effects of the IRA on the pharmaceutical industry
A practical guide to the accounting and tax issues a pharmaceutical company might face in its financial reporting for drug pricing rebates, and more.
Effects of the IRA on the pharmaceutical industry
A practical guide for pharmaceutical companies
KPMG Resources from Pharmaceutical Compliance Conference (PCC) 2023
Join us on Wednesday, April 26, 2023 | 2:15 pm-3:00 pm ET—Using Data, Analytics, and Industry Learnings to Enhance Auditing and Monitoring across your PSPs
April 26, 2023
How customer data platforms harness value for pharmaceutical companies
Salesforce solutions for life sciences can help transform patient and provider engagement
ServiceNow | Pharmaceutical industry case study
Transforming service management for a global pharmaceutical company
ServiceNow | Pharmaceutical industry case study
Transforming service management for a global pharmaceutical company
Biopharma deal trends outlook for 2023: Q3’22 M&A trends in lifesciences
Near-term headwinds, with possible run on small biotechs on the horizon
Biopharma deal trends outlook for 2022: Q2’22 M&A trends in LS
Deal strategies will focus on risk mitigation, accelerated development, or risk sharing (licensing, partnerships, R&D collaborations).
Generics 2030: Three strategies to curb the downward spiral
By 2030, generics manufacturers will need to shift from the status quo and explore one of three avenues for change.
Life Sciences Gross to Net: Getting it Right
This paper explores how manufacturers are able to improve and optimize their GTN processes in a fast-paced market.